02500 VENUS MEDTECH-B
Trading Add to PorfolioKey Financial Ratio (Fiscal Year: 12/2024) | |||
Current | 2.22X | Oper Margin | N/A |
---|---|---|---|
LT Debt/Equity | 14.2% | Net Margin | N/A |
Total Debt/Equity | 16.7% | Return on Equity | N/A |
Price/Book | 0.49X | Return on Assets | N/A |
(HKD 2.600) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
Net Profit (MHKD) | -759.67 | -794.55 | -1,185.89 | -456.99 | -215.98 |
---|---|---|---|---|---|
Net Profit Growth (%) | +4.4 | +33.0 | -159.5 | -111.6 | +49.3 |
Earnings Per Share (HKD) | -1.735 | -1.815 | -2.708 | -1.042 | -0.528 |
Earnings Per Share Growth (%) | +4.4 | +33.0 | -159.9 | -97.5 | +61.4 |
Dividend Per Share (HKD) | No dividend | No dividend | No dividend | No dividend | No dividend |
P/E* (X) | N/A | N/A | N/A | N/A | N/A |
Yield (%) | N/A | N/A | N/A | N/A | N/A |
Dividend Share (%) | N/A | N/A | N/A | N/A | N/A |
Book NAV (HKD) | 5.332 | 7.257 | 9.172 | 12.607 | 10.706 |
Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
(RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
Cover Period (mths) | 12 | 12 | NA | 12 |
---|---|---|---|---|
Turnover | 470.833 | 491.373 | -4.2 | 406.461 |
Operating Result | -736.559 | -740.081 | -0.5 | -1,142 |
Associates | -4.154 | -12.381 | -66.4 | -13.943 |
Profit Before Taxation | -740.713 | -752.462 | -1.6 | -1,156 |
Taxation | -23.34 | -6.284 | +271.4 | -34.302 |
Profit /( Loss) After Taxation | -717.373 | -746.178 | -3.9 | -1,122 |
Minority Interests | -3.066 | -25.302 | -87.9 | -64.343 |
Net Profit | -714.307 | -720.876 | -0.9 | -1,058 |
Earnings Per Share () | -1.7348 | -1.8145 | -4.4 | -2.7082 |
Announcement Date | 2025-03-28 | 2024-03-28 | NA | 2023-03-31 |
* Annualised
Last Update Time: 2025-07-22 21:40:25